Milene L. Brownlow
- Neurology top 0.1%
- Neuroinflammation and Neurodegeneration Mechanisms 6
- Biological Psychiatry top 0.5%
- Tryptophan and brain disorders 3
- Physiology top 0.1%
- Alzheimer's disease research and treatments 8
- Diet and metabolism studies 6
- Adipose Tissue and Metabolism 4
- Cellular and Molecular Neuroscience top 0.5%
- Developmental Neuroscience top 1%
-
- Diet, Metabolism, and Disease 3
-
- Mitochondrial Function and Pathology 2
-
- Neuroendocrine regulation and behavior 2
Milene L. Brownlow
19 papers receiving 9.0k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Neurology 2.4k
- Biological Psychiatry 665
- Physiology 6.2k
- Cellular and Molecular Neuroscience 2.2k
- Developmental Neuroscience 344
Countries citing papers authored by Milene L. Brownlow
This map shows the geographic impact of Milene L. Brownlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milene L. Brownlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milene L. Brownlow more than expected).
Fields of papers citing papers by Milene L. Brownlow
This network shows the impact of papers produced by Milene L. Brownlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milene L. Brownlow. The network helps show where Milene L. Brownlow may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Milene L. Brownlow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 12 | |
| 3 | 2022 | 4 | |
| 4 | 2022 | 16 | |
| 5 | 2022 | 8 | |
| 6 | 2021 | 10 | |
| 7 | 2021 | 28 | |
| 8 | 2017 | 15 | |
| 9 | 2017 | 44 | |
| 10 | 2017 | 80 | |
| 11 | 2017 | 32 | |
| 12 | 2016 | 33 | |
| 13 | 2015 | 16 | |
| 14 | 2014 | 60 | |
| 15 | 2014 | 3 | |
| 16 | 2013 | 114 | |
| 17 | 2013 | 33 | |
| 18 | 2013 | 92 | |
| 19 | Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathybreakdown → | 2012 | 8402 |
About Milene L. Brownlow
Milene L. Brownlow is a scholar working on Biological Psychiatry, Neurology and Physiology, having authored 19 papers that have together received 9.0k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (8 papers), Diet and metabolism studies (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Adipose Tissue and Metabolism (4 papers), Tryptophan and brain disorders (3 papers), Diet, Metabolism, and Disease (3 papers), Mitochondrial Function and Pathology (2 papers) and Neuroendocrine regulation and behavior (2 papers). The work is most often cited by research in Neurology (2.4k citations), Biological Psychiatry (665 citations) and Physiology (6.2k citations). Milene L. Brownlow has collaborated with scholars based in United States, Brazil and China. Frequent co-authors include Marcia N. Gordon, Dave Morgan, Maj-Linda B. Selenica, Daniel C. Lee, Chad A. Dickey, Jeffy P. Jimenez, Gabriela Peña, Ryan Jankord, Leif Benner and Dominic P. D’Agostino. Their work appears in journals such as PLoS ONE, Frontiers in Molecular Neuroscience, Neurobiology of Aging, GeroScience and Behavioural Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.